Earnings, Dividends, Sales Driving Nutrition - Pharma Stocks: Muscle Warfare, GNC, Vitamin Shoppe, Sterotaxis, Organovo
CORAL SPRINGS, Florida, October 24, 2013 /PRNewswire/ --
Market news updates and reports for today's active sports nutrition & pharmaceutical companies: Muscle Warfare International Inc. (OTC: MWAR), GNC Holdings, Inc. (NYSE: GNC), Vitamin Shoppe, Inc. (NYSE: VSI), Stereotaxis, Inc. (NASDAQ: STXS) and Organovo Holdings, Inc. (NYSE: ONVO).
Muscle Warfare International Inc. (OTC: MWAR) CEO discusses 3rd Quarter Disclosure - Muscle Warfare International is a cutting edge sports nutrition manufacturer that is passionately driven to create and distribute the absolute highest quality products in the marketplace. Daniel Amato, President and CEO of Muscle Warfare stated "I am very excited about the 3rd quarter financials our revenues have increased over the 2nd quarter numbers by 40 percent, gross profits are up by 60% and our net loss is down by 24%, the reported numbers represent consolidated financials for all three of MWAR's companies as well as MWAR. Muscle Warfare is in the growth stage of our company and spending money on advertising, acquiring inventory, attending trade shows and building a strong and viable sales team. We will continue to search for areas to improve within MWAR and continue to increase our revenues as well as profits."
Read the full release athttp://www.fnmprofiles.com/profiles-mwar.html
Muscle Warfare has been conducting business since 2002 with annual revenues of approximately $1,000,000 (one million dollars) plus. The company has been recognized as a proven winner within the industry with many successes and proven track record marketing and branding sports nutrition products through multiple brands and marketing strategies. Some of Muscle Warfare clients consist of GNC, Inc., Vitamin Shoppe, Europa Sports Products, Fitness First USA and many others.
The Board of Directors of GNC Holdings, Inc. (NYSE: GNC) (the "Company") authorized and declared the quarterly cash dividend for the fourth quarter of 2013 of $0.15 per share of the Company's common stock. The dividend will be paid on or about December 27, 2013 to stockholders of record as of the close of business on December 13, 2013.
Vitamin Shoppe, Inc. (NYSE: VSI), a leading multi-channel specialty retailer of nutritional products, today announced that the Company will release its fiscal third quarter 2013 financial results before the market open on Tuesday, November 5, 2013. A conference call will be webcast the same day beginning at 8:30 a.m. Eastern Time. Interested investors and other parties may listen to the webcast of the conference call by logging on to the Investor Relations section of the Company's website at http://www.vitaminshoppe.com. A telephonic replay will be available for one week beginning at 11:30 a.m. Eastern Time on November 5, 2013. The replay can be accessed by dialing 1-877-870-5176 or for international callers 1-858-384-5517. The passcode for the replay is 6370052. The webcast will also be archived on the Company's website at http://www.vitaminshoppe.com.
Stereotaxis, Inc. (NASDAQ: STXS) announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has classified its Niobe(R) Magnetic Navigation System as a C2 medical device. The C2 classification recognizes the Niobe system as a new, distinctive technology with clinical benefits and is the highest of five reimbursement categories for medical devices in Japan. The MHLW also approved reimbursement for two electrophysiology (EP) ablation catheters compatible with Niobe magnetic navigation, effective October 1, 2013.
Organovo Holdings, Inc. (NYSE: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, today provided a summary of the data presented at the 3rd Annual Cell Therapy Bioprocessing Conference in Bethesda, MD International Bioprocessing Conference on October 22, 2013. Building on data first presented at the Experimental Biology conference in April 2013, the company presented data demonstrating retention of key liver functions in bioprinted tissues for up to 40 days, longer than one month.
MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, recently announced that Sydney Rollock has joined the company as Chief Marketing Officer. In this role, Rollock will oversee global brand management, global marketing and sales, as well as help lead MusclePharm's corporate strategy to ultimately grow product lines and revenue streams..
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FNMG was compensated one thousand two hundred fifty dollars for the dissemination of this news release by Muscle Warfare International Inc. (OTC: MWAR).
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group, LLC